Alterations of INPP4B, PIK3CA and pAkt of the PI3K pathway are associated with squamous cell carcinoma of the lung
Open Access
- 5 February 2014
- journal article
- research article
- Published by Wiley in Cancer Medicine
- Vol. 3 (2) , 337-348
Abstract
The aim of the study was to investigate how alterations in the PI3K pathway correlate with non‐small cell lung cancer subtypes squamous cell carcinoma (SSC) and adenocarcinoma (ADCA). We analyzed copy number variation and protein expression of INPP4B, protein expression of pAkt, PDPK1, and PTEN and mutational status of PIK3CA and PTEN in 180 cases. Nineteen% displayed loss of INPP4B copy, whereas 47% lacked expression, both showing correlation with SCC. Elevated pAkt expression was seen in 63% of all cases, also correlating to SCC. PDPK1 was expressed in 70%, more in male than female patients. Regarding PTEN, 50% displayed loss of expression, of which seven were identified with mutations in the phosphatase domain. We detected nine cases (5%) of PIK3CA mutations, all identified as the E545K hot spot mutation in the helical domain, all except one in SCC. When analyzing all PI3K pathway components together, we show that patients with at least one alteration in the PI3K pathway are twice as likely to have SCC, than ADCA. Interestingly, we also found a strong correlation between high pAkt expression and PTEN expression. As comparison, we also analyzed mitogen‐activated protein kinase (MAPK) pathway genes, where we identified fifteen KRAS mutations (8%) and one BRAF mutation (1%), significantly associated to ADCA. No association was found to the Gly972Arg polymorphism of IRS‐1, involved in activation of both PI3K and MAPK pathways. In conclusion, we show here that several components of the PI3K pathway, alone and in combination, are correlated to development of SCC of the lung.Keywords
This publication has 47 references indexed in Scilit:
- Phosphatases: The New Brakes for Cancer Development?Enzyme Research, 2011
- Decreased Expression and Androgen Regulation of the Tumor Suppressor Gene INPP4B in Prostate CancerCancer Research, 2011
- Inositol polyphosphate 4-phosphatase II regulates PI3K/Akt signaling and is lost in human basal-like breast cancersProceedings of the National Academy of Sciences, 2010
- Integrative Genomic Profiling of Human Prostate CancerCancer Cell, 2010
- Evidence that Inositol Polyphosphate 4-Phosphatase Type II Is a Tumor Suppressor that Inhibits PI3K SignalingCancer Cell, 2009
- PTEN regulation by Akt–EGR1–ARF–PTEN axisThe EMBO Journal, 2008
- PIK3CA Mutations and Copy Number Gains in Human Lung CancersCancer Research, 2008
- An immunohistochemical perspective of PPARβ and one of its putative targets PDK1 in normal ovaries, benign and malignant ovarian tumoursBritish Journal of Cancer, 2008
- Drivers and passengersNature, 2007
- Mutations of the BRAF gene in human cancerNature, 2002